A new study has discovered a highly promising therapy for patients with cognitive and behavioral variant frontotemporal dementia, the second most common type of dementia in people under the age of 60, resulting in the stabilization of what would otherwise be escalating behavioral issues and the slowing of disease-related brain shrinkage
A Monash University led study has found a promising new treatment for patients with behavioural variant frontotemporal dementia, the second most common form of dementia in the under 60s – resulting in a stabilising of what would normally be escalating behavioural issues, and a slowing of brain shrinkage due to the disease.
A Monash University led study has found a promising new treatment for patients with behavioural variant frontotemporal dementia, the second most common
Highlights: Positive phase 2a clinical trial results for IHL-42X with 60% of trial participants experiencing at least a 55% reduction in the Apnoea Hypopnea.